BMRN
Price
$70.13
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Earnings call today
FOLD
Price
$11.52
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
6 days until earnings call
Ad is loading...

BMRN vs FOLD

Header iconBMRN vs FOLD Comparison
Open Charts BMRN vs FOLDBanner chart's image
BioMarin Pharmaceutical
Price$70.13
Change-$0.00 (-0.00%)
Volume$1.54M
CapitalizationN/A
Amicus Therapeutics
Price$11.52
Change-$0.00 (-0.00%)
Volume$2.1M
CapitalizationN/A
View a ticker or compare two or three
BMRN vs FOLD Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BMRN vs. FOLD commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and FOLD is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (BMRN: $70.14 vs. FOLD: $11.52)
Brand notoriety: BMRN and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 68% vs. FOLD: 78%
Market capitalization -- BMRN: $13.38B vs. FOLD: $3.18B
BMRN [@Biotechnology] is valued at $13.38B. FOLD’s [@Biotechnology] market capitalization is $3.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, FOLD is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish while FOLD’s TA Score has 6 bullish TA indicator(s).

  • BMRN’s TA Score: 4 bullish, 4 bearish.
  • FOLD’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, FOLD is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а -0.20% price change this week, while FOLD (@Biotechnology) price change was -4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 20, 2025.

FOLD is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($13.4B) has a higher market cap than FOLD($3.18B). FOLD YTD gains are higher at: -18.816 vs. BMRN (-27.256). BMRN has higher annual earnings (EBITDA): 421M vs. FOLD (-40.33M). BMRN has more cash in the bank: 1.22B vs. FOLD (260M). FOLD has less debt than BMRN: FOLD (444M) vs BMRN (1.1B). BMRN has higher revenues than FOLD: BMRN (2.59B) vs FOLD (456M).
BMRNFOLDBMRN / FOLD
Capitalization13.4B3.18B422%
EBITDA421M-40.33M-1,044%
Gain YTD-27.256-18.816145%
P/E Ratio53.24N/A-
Revenue2.59B456M568%
Total Cash1.22B260M471%
Total Debt1.1B444M248%
FUNDAMENTALS RATINGS
BMRN vs FOLD: Fundamental Ratings
BMRN
FOLD
OUTLOOK RATING
1..100
1058
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
9076
SMR RATING
1..100
8398
PRICE GROWTH RATING
1..100
6246
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (76) in the Biotechnology industry is in the same range as FOLD (81). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

FOLD's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as BMRN (90). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (83) in the Biotechnology industry is in the same range as FOLD (98). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

FOLD's Price Growth Rating (46) in the Biotechnology industry is in the same range as BMRN (62). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (98) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFOLD
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 19 days ago
65%
Bullish Trend 13 days ago
74%
Declines
ODDS (%)
Bearish Trend 13 days ago
57%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with IBO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+0.59%
IBO - BMRN
56%
Loosely correlated
-4.31%
SRPT - BMRN
45%
Loosely correlated
-0.67%
AXON - BMRN
42%
Loosely correlated
+0.06%
ITOS - BMRN
41%
Loosely correlated
+2.41%
FGEN - BMRN
41%
Loosely correlated
-1.95%
More